Evidence map›Paper›PMID 29740734›Full record

ReviewCurrent HIV/AIDS reports2018

Syringe Decriminalization Advocacy in Red States: Lessons from the North Carolina Harm Reduction Coalition.

David H Cloud, Tessie Castillo, Lauren Brinkley-Rubinstein, Manisha Dubey, Robert Childs

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current HIV/AIDS reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Article
  3. Substance use & misuse · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

David H CloudDepartment of Behavioral Sciences and Health Education, Rollins School of Public Health, Emory University, 1518 Clifton Rd, Atlanta, GA, 30322, USA. dcloud@emory.edu.
Tessie CastilloNorth Carolina Harm Reduction Coalition, Wilmington, NC, USA.
Lauren Brinkley-RubinsteinDepartment of Social Medicine, University of North Carolina, Chapel Hill, NC, USA.
Manisha DubeyCenter for Health Equity Research, University of North Carolina, Chapel Hill, NC, USA.
Robert ChildsNorth Carolina Harm Reduction Coalition, Wilmington, NC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewSyringe access programs (SAPs) are cornerstone harm reduction interventions for combatting the national opioid epidemic. The goal of this paper is to describe effective advocacy strategies for enacting syringe decriminalization legislation to foster the expansion of SAPs in high-need areas amidst political opposition. RECENT

findingsDecades or research shows that SAPs prevent the transmission of HIV among people who inject drugs (PWID) and are a cost-effective tool for linking PWID to medical care, health education, and social services. In the USA, state laws criminalizing distribution and possession of syringes impede the expansion of SAPs into areas where they are sorely needed. In 2016, North Carolina became the first state to legalize SAPs with a Republican super majority. This paper distills strategies for community organizations seeking to advance syringe decriminalization legislation in politically conservative states with histories of prioritizing punitive sanctions over public health responses to drug use.

Indexed as

Harm ReductionCriminal LawDrug OverdoseHepatitis CHIV InfectionsHumansLaw EnforcementNeedle-Exchange ProgramsNorth CarolinaPolitical SystemsPublic HealthSubstance Abuse, IntravenousSyringesHarm reductionHIVNorth CarolinaSyringe access programs

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.